StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Moderna (MRNA) Falls 5% Following Positive Pfizer COVID-19 Oral Antiviral Treatment Data
November 5, 2021 7:01 AM
Moderna (NASDAQ: MRNA) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Trader Talk
Next Articles
Moderna (MRNA) Requests to Expand Conditional Marketing Authorization for its COVID-19 Vaccine in the EU to Include Children Ages 6-11 Years
November 9, 2021 8:33 AM
Moderna (MRNA) Hits Low, Down 25% on Session
November 5, 2021 12:51 PM
Moderna (MRNA) PT Lowered to $325 at Jefferies
November 5, 2021 8:24 AM
